Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F E Blaney

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Molecular Graphics|September 1, 1993
MAMBAs: a real-time graphics environment for QSARF E Blaney, D Naylor, J Woods
Journal of Molecular Graphics|June 1, 1995
Molecular surface comparison. 2. Similarity of electrostatic vector fields in drug designF E Blaney, C Edge, R W Phippen
Journal of Molecular Graphics|December 1, 1995
Models of ion pores in N-type voltage-gated calcium channelsS W Doughty, F E Blaney, W G Richards
Journal of Computer-Aided Molecular Design|June 1, 1992
Conformational studies on (+)-anatoxin-a and derivativesP E Thompson, D T Manallack, F E Blaney, et al.
Protein Engineering|May 30, 1998
A molecular mechanism for toxin block in N-type calcium channelsS W Doughty, F E Blaney, B S Orlek, et al.
Biochemical Society Transactions|October 28, 2004
Evidence to support a spectrum of active states for the glucagon receptorN Strudwick, N Bhogal, N A Evans, et al.
Journal of Medicinal Chemistry|December 1, 1983
Anilides related to substituted benzamides. Potential antipsychotic activity of N-(4-amino-5-chloro-2-methoxyphenyl)-1-(phenylmethyl)-4-piperidinecarboxamideF E Blaney, M S Clark, D V Gardner, et al.
Journal of Medicinal Chemistry|September 1, 1991
Comparison of azabicyclic esters and oxadiazoles as ligands for the muscarinic receptorB S Orlek, F E Blaney, F Brown, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 7, 2000
Regioselective hydroxylation of debrisoquine by cytochrome P4502D6: implications for active site modellingT Lightfoot, S W Ellis, J Mahling, et al.
Journal of Medicinal Chemistry|December 6, 1996
Synthesis, biological activity, and molecular modeling of selective 5-HT(2C/2B) receptor antagonistsI T Forbes, S Dabbs, D M Duckworth, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Molecular Graphics|September 1, 1993
MAMBAs: a real-time graphics environment for QSARF E Blaney, D Naylor, J Woods
Journal of Molecular Graphics|June 1, 1995
Molecular surface comparison. 2. Similarity of electrostatic vector fields in drug designF E Blaney, C Edge, R W Phippen
Journal of Molecular Graphics|December 1, 1995
Models of ion pores in N-type voltage-gated calcium channelsS W Doughty, F E Blaney, W G Richards
Journal of Computer-Aided Molecular Design|June 1, 1992
Conformational studies on (+)-anatoxin-a and derivativesP E Thompson, D T Manallack, F E Blaney, et al.
Protein Engineering|May 30, 1998
A molecular mechanism for toxin block in N-type calcium channelsS W Doughty, F E Blaney, B S Orlek, et al.
Biochemical Society Transactions|October 28, 2004
Evidence to support a spectrum of active states for the glucagon receptorN Strudwick, N Bhogal, N A Evans, et al.
Journal of Medicinal Chemistry|December 1, 1983
Anilides related to substituted benzamides. Potential antipsychotic activity of N-(4-amino-5-chloro-2-methoxyphenyl)-1-(phenylmethyl)-4-piperidinecarboxamideF E Blaney, M S Clark, D V Gardner, et al.
Journal of Medicinal Chemistry|September 1, 1991
Comparison of azabicyclic esters and oxadiazoles as ligands for the muscarinic receptorB S Orlek, F E Blaney, F Brown, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 7, 2000
Regioselective hydroxylation of debrisoquine by cytochrome P4502D6: implications for active site modellingT Lightfoot, S W Ellis, J Mahling, et al.
Journal of Medicinal Chemistry|December 6, 1996
Synthesis, biological activity, and molecular modeling of selective 5-HT(2C/2B) receptor antagonistsI T Forbes, S Dabbs, D M Duckworth, et al.
Pageof 2